診斷生物芯片：創新和增長機會

對精準醫療和低成本即時診斷平台的巨大需求預計將推動診斷生物芯片市場。 創新的診斷生物芯片代表了基因檢測、癌症診斷和治療、傳染病管理、慢性病管理、過敏面板測試、藥物測試等的增長機會，因為它們可以檢測不同類型的生物分子。。

本報告考察了全球診斷生物芯片市場，介紹了技術優勢和挑戰，分析了影響市場增長的各種因素、技術路線圖、招聘趨勢、資金、併購和專利。它總結了趨勢、增長機會分析和更多的。

內容

戰略要務

• 增長問題
• 戰略要務 8 (TM)
• 三大戰略要務的影響
• 增長機會推動增長PipelineEngine (TM)
• 調查方法

增長機會分析

• 用於小型和多種生物傳感設備的診斷生物芯片
• 診斷生物芯片：新微陣列格式和製造技術的進展
• 生物芯片作為小型設備可實現高通量測試
• 生物芯片的許多用途
• 分類
• 診斷生物芯片行業的增長動力：對個性化醫療的需求不斷增加
• 制約診斷生物芯片行業發展的因素：成本高
• 診斷生物芯片行業：一個不斷增長且分散的市場
• 分析範圍

技術分析：DNA 生物芯片

• DNA 生物芯片能夠檢測疾病的遺傳生物標誌物
• 旨在降低設備成本的新型 DNA 生物芯片製造技術
• 診斷性 DNA 生物芯片：對生物標誌物發現的重大影響
• DNA 生物芯片：競爭格局

技術分析：蛋白質生物芯片

• 用於蛋白質分析、疾病生物標誌物檢測和蛋白質功能鑑定的蛋白質生物芯片
• 專注於高靈敏度和固定化效率的新型蛋白質生物芯片製造技術
• 診斷性蛋白質生物芯片：對生物標誌物發現的重大影響
• 蛋白質生物芯片：競爭格局

技術分析：微流控生物芯片

• 用於 POC 疾病診斷的微流體生物芯片
• 專注於高通量生產的新型微流控生物芯片製造技術
• 診斷性微流體生物芯片：對核酸和蛋白質生物標誌物鑑定的重大影響
• 微流體生物芯片：競爭格局

創新指數

• 微流體診斷生物芯片部門：展示先進技術的發展和採用趨勢
• 微流控生物芯片的低成本和便攜性吸引了研究
• 用於低成本多路復用 LOC 設備的微流體
• 診斷生物芯片技術在體內連續監測設備方面取得進展
• 微流體生物芯片：便攜性、成本效益和易於製造
• 近期併購活動分析：2019-2022 年
• 政府資金分析：2019-2022 年
• 私人籌款活動概況：2019-2022 年

專利分析

增長機會領域

• 發展機會 1：分子電子學
• 增長機會 2：微電極點陣 (MEDA) 生物芯片
• 增長機會 3：智能生物芯片平台

主要行業參與者

附錄

下一步

Rapidly Evolving Microfluidic Biochips Enable Low-cost Point-of-care Diagnostics

Biological systems are complex and involve several biological reactions and biomolecules. Understanding the biological reactions and identifying the associated biomolecules will help in the development of accurate diagnostics and aid precision medicine. Yet the high number of molecules often requires multiple tests or bulky instruments. To overcome this need, diagnostic biochip technology offers a miniaturized multiplexing sensing platform. A biochip is a solid substrate with a multitude of miniaturized test sites that have immobilized probes to capture and detect the target biomolecules. While biochips can have several applications, current research focuses on diagnostic biochips.

The huge demand for precision medicine and low-cost point-of-care diagnostic platforms will drive the market. However, key players must focus on reducing the costs of DNA and protein biochips, meeting regulatory standards, and increasing awareness among users.

The global diagnostic biochips industry is advancing, offering new fluidic control technologies, probe immobilization techniques, signal detection technologies, and data analytics. As they can detect different kinds of biomolecules, innovative diagnostic biochips provide growth opportunities for genetic testing, cancer diagnostics and therapy, infectious diseases management, chronic disease management, allergy panel testing, and drug testing. This study focuses on DNA biochips, protein biochips, and microfluidic biochips.

The key elements of this analysis include an overview of the global diagnostic biochips industry supported by the following:

• Technology advantages and disadvantages
• Industry growth drivers and restraints
• Key participants in different industry segments
• Technology roadmap
• SWOT analysis of diagnostic biochips
• Adoption, funding, and M&A trends
• Impact of the different technology segments
• Patent filing trends
• Growth opportunities for key companies

Table of Contents

Strategic Imperatives

• Why Is It Increasingly Difficult to Grow?The Strategic Imperative 8™: Factors Creating Pressure on Growth
• The Strategic Imperative 8™
• The Impact of the Top 3 Strategic Imperatives on the Diagnostic Biochips Industry
• Growth Opportunities Fuel the Growth Pipeline Engine™
• Research Methodology

Growth Opportunity Analysis

• Diagnostic Biochips for Miniature and Multiplexing Biosensing Devices
• Diagnostic Biochips Are Advancing with New Microarray Formats and Fabrication Technologies
• Biochips as Miniature Devices Enable High-throughput Testing
• Biochips Have a Multitude of Applications
• Segmentation
• Increasing Demand for Personalized Medicine as a Growth Driver for Diagnostic Biochips Industry
• High Costs as a Growth Restraint for Diagnostic Biochips Industry
• Diagnostic Biochips Industry as a Growing and Fragmented Market
• Scope of Analysis

Technology Analysis: DNA Biochips

• DNA Biochips Enabling Detection of Genetic Biomarkers of Disease
• Emerging DNA Biochip Fabrication Technologies Aiming for Low Device Costs
• Diagnostic DNA Biochips Have High Impact on Biomarkers Discovery
• DNA Biochips-Competitive Environment
• DNA Biochips-Competitive Environment (continued)

Technology Analysis: Protein Biochips

• Protein Biochips for Protein Profiling, Disease Biomarkers Detection, and Protein Functions Identification
• Emerging Protein Biochip Fabrication Technologies Focusing on High Sensitivity and Immobilization Efficiency
• Diagnostic Protein Biochips Have High Impact on Biomarkers Discovery
• Protein Biochips-Competitive Environment
• Protein Biochips-Competitive Environment (continued)

Technology Analysis: Microfluidic Biochips

• Microfluidic Biochips for Disease Diagnosis at POC
• Emerging Microfluidic Biochip Fabrication Technologies Focusing on High-throughput Production
• Diagnostic Microfluidic Biochips Have High Impact on Identification of Nucleic Acid and Protein Biomarkers
• Microfluidic Biochips-Competitive Environment
• Microfluidic Biochips-Competitive Environment (continued)
• Microfluidic Biochips-Competitive Environment (continued)

Innovation Indicators

• Microfluidic Diagnostic Biochips Segment Exhibits High Technology Evolution and Adoption Trends
• Low Cost and Portability of Microfluidic Biochips Attracting Research
• Microfluidics for Low-cost Multiplexing LOC Devices
• Diagnostic Biochip Technology Advancing toward In Vivo Continuous Monitoring Devices
• Microfluidic Biochips Excel in Portability, Cost Efficiency, and Ease of Fabrication
• Recent M&A Activity Analysis, 2019-2022
• Government Funding Analysis, 2019-2022
• Private Funding Activities Snapshot, 2019-2022
• Private Funding Activities Snapshot, 2019-2022 (continued)

Patent Analysis

• Innovation Themes Include Microfluidic and Microarray Designs and Data Processing Technologies
• Key Patents
• Key Patents (continued)
• Key Patents (continued)

Growth Opportunity Universe

• Growth Opportunity 1: Molecular Electronics
• Growth Opportunity 1: Molecular Electronics (continued)
• Growth Opportunity 2: Micro-electrode-dot Array (MEDA) Biochips
• Growth Opportunity 2: MEDA Biochips (continued)
• Growth Opportunity 3: Intelligent Biochip Platform
• Growth Opportunity 3: Intelligent Biochip Platform (continued)

Key Industry Participants

• Database of Key Industry Participants

Appendix

• Technology Readiness Levels (TRL): Explanation

Next Steps

• Your Next Steps
• Why Frost, Why Now?
• Legal Disclaimer